1. Food and Agricultural Organization: Food balance sheets. http://www.fao.
org.
2. Butt MS, Sultan MT: Coffee and its consumption: Benefits and risks. Crit
Rev Food Sci Nutr 2011, 51:363–373.
3. Spiller MA: The chemical components of coffee. In Caffeine. Boca Raton:
CRC Press; 1998:97–161.
4. Castellanos FX, Rapoport JL: Effects of caffeine on development and
behavior in infancy and childhood: a review of the published literature.
Food Chem Toxicol 2002, 40:1235–1242.
5. HealthCanada: Fact Sheet Caffeine and Your Health.2003. http://www.hc-sc.
gc.ca/foodaliment/dg/ecaffeine.html.
6. Hasling C, Sondergaard K, Charles P, Mosekilde L: Calcium metabolism in
postmenopausal osteoporotic women is determined by dietary calcium
and coffee intake. J Nutr 1992, 122:1119–1126.
7. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL: Caffeine intake increases
the rate of bone loss in elderly women and interacts with vitamin D
receptor genotypes. Am J Clin Nutr 2001, 74:694–700.
8. Hannan MT, Felson DT, Dawson-Hughes B, Tucker TL, Cupples LA, Wilson
PW, Kiel DP: Risk factors for longitudinal bone loss in elderly men and
women: the Framingham Osteoporosis Study. J Bone Miner Res 2000,
15:710–720.
9. Izuora K, Twombly JG, Whitford GM, Demertzis J, Pacifici R, Whyte MP:
Skeletal fluorosis from brewed tea. J Clin Endocrinol Metab 2011, 96:2318–
2324.
10. Heaney RP: Bone mass, nutrition, and other lifestyle factors. Nutr Rev
1996, 54:S3–10.
11. Heaney RP: Effects of caffeine on bone and the calcium economy. Food
Chem Toxicol 2002, 40:1263–1270.
12. Heaney RP, Recker RR: Effects of nitrogen, phosphorus, and caffeine on
calcium balance in women. J Lab Clin Med 1982, 99:46–55.
13. Massey LK, Whitling SJ: Caffeine, urinary calcium, calcium metabolism and
bone. J Nutr 1993, 123:1611–1614.
14. Kreiger N, Gross A, Hunter G: Dietary factors and fracture in
postmenopausal women: a case–control study. Int J Epidemiol 1992,
21:953–958.
15. Huopio J, Kroger H, Honkanen R, Saarikoski S, Alhava E: Risk factors for
perimenopausal fractures: a prospective study. Osteoporos Int 2000,
11:219–227.
16. Gong G, Stern HS, Cheng SC, Fong N, Mordeson J, Deng HW, Recker RR:
The association of bone mineral density with vitamin D receptor gene
polymorphisms. Osteoporos Int 1999, 9:55–84.
17. Woods RJ, Fleet JC: The genetics of osteoporosis: vitamin D receptor
polymorphisms. Annu Rev Nutr 1998, 18:233–258.
18. Rapuri PB, Gallagher JC, Nawaz Z: Caffeine decreases vitamin D receptor
protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase
activity in human osteoblast cells. J Steroid Biochem Mol Biol 2007,
103:368–371.
19. Barone JJ, Roberts HR: Caffeine consumption. Food Chem Toxicol 1996,
34:119–129.
20. Gates S, Miners JO: Cytochrome P450 isoform selectivity in human
hepatic theobromine metabolism. Br J Clin Pharmacol 1999, 47:299–305.
21. Ullrich D, Compagnone D, Munch B, Brandes A, Hille H, Bircher J: Urinary
caffeine metabolites in man. Age-dependent changes and pattern in
various clinical situations. Eur J Clin Pharmacol 1992, 43:167–172.
22. Taft JL, French M, Danks JA, Larkins RG: Opposing actions of
methylxanthines and dibutyryl cyclic AMP on 1,25 dihydroxyvitamin D3
production and calcium fluxes in isolated chick renal tubules. Biochem
Biphys Res Commun 1984, 121:355–363.
23. Jorde R, Sundsfjord J, Bonaa KH: Determinants of serum calcium in men
and women. The Tromso Study. Eur J Epidemiol 2001, 17:1117–1123.
24. Tagliabue A, Terracina D, Cena H, Turconi G, Lanzola E, Montomolli C:
Coffee induced thermogenesis and skin temperature. Int J Obes Relat
Metab Disord 1994, 18:537–541.
25. Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS: Normal caffeine
consumption: influence on thermogenesis and daily energy expenditure
in lean and postobese human volunteers. Am J Clin Nutr 1989, 49:44–50.
26. Graham TE: Caffeine and exercise: metabolism, endurance and
performance. Sports Med 2001, 31:785–807.
27. Astrup A: Thermogenic drugs as a strategy for treatment of obesity.
Endocrine 2000, 13:207–212.
28. Ryu S, Choi SK, Joung SS, Suh H, Cha YS, Lee S, Lim K: Caffeine and
lipolytic food component increases endurance performance in rats and
athletes. J Nutr Sci Vitaminol 2001, 47:139–146.
29. Keijzers GB, De Galan BE, Tack CJ, Smits P: Caffeine can decrease insulin
sensitivity in humans. Diabetes Care 2002, 25:364–369.
30. Kamycheva E, Joakimsen RM, Jorde R: Intakes of calcium and vitmin D
predict body mass index in the population of Northern Norway. J Nutr
2003, 133:102–106.
31. Riedt CS, Cifuentes M, Stahl T, Chowdhury HA, Schlussel Y, Shapses SA:
Overweight postmenopausal women lose bone with moderate weight
reduction and 1 g/day calcium intake. J Bone Miner Res 2005, 20:455–463.
32. Tzotas T, Papadopoulou FG, Tsiomaoos K, Karras S, Gastaris K, Perros P,
Krassas GE: Rising serum 25-hydroxy-vitamin D levels after weight loss in
obese women correlate with improvement in insulin resistance. J Clin
Endocrinol Metab 2010, 95:4251–4257.
33. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, Stehle P,
Koertke H, Koerfer R: Vitamin D supplementation enhances the beneficial
effects of weight loss on cardiovascular disease risk markers. Am J Clin
Nutr 2009, 89:1321–1327.
34. Higdon JV, Frei B: Coffee and health: a review of recent human research.
Crit Rev Food Sci Nutr 2006, 46:101–123.
35. Schneider C, Serge T: Green tea: potential health benefits. Am Fam
Physician 2009, 79:591–594.
36. Greenberg JA, Axen KV, Schnoll R, Boozer CN: Coffee, tea and diabetes: the
role of weight loss and caffeine. Int J Obes (Lond) 2005, 29:1121–1129.
37. He RR, Chen L, Lin BH, Matsui Y, Yao XS, Kurihara H: Beneficial effects of
oolong tea consumption on diet-induced overweight and obese
subjects. Chin J Integr Med 2009, 15:34–41.
38. Thom E: The effect of chlorogenic acid enriched coffee on glucose
absorption in healthy volunteers and its effect on body mass when used
long-term in overweight and obese people. J Int Med Res 2007,
35:900–908.